From the Corporate World to Venture Capital
This article was originally published in Start Up
Executive Summary
In making the move from the corporate device world, i.e., Boston Scientific to venture capital, at SVLS, a leading venture firm, David Milne has found the two worlds--while critically linked--are strikingly different.